<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet12938</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-12938</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Ассоциации индекса массы тела с уровнем свободных жирных кислот у мужчин</article-title><trans-title-group xml:lang="en"><trans-title>Associations of body mass index with the level of free fatty acids in men</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0436-2549</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шрамко</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Shramko</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шрамко Виктория Сергеевна - к.м.н.</p><p>630089, Новосибирск, ул. Бориса Богаткова, д. 175/1</p><p>ResearcherID ABG-9543-2020; Scopus Author ID 57194556107</p></bio><bio xml:lang="en"><p>Viktoriya S. Shramko - MD, PhD.</p><p>175/1 Bogatkov street, 630089 Novosibirsk</p><p>ResearcherID ABG-9543-2020; Scopus Author ID 57194556107</p></bio><email xlink:type="simple">Nosova@211.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2268-4186</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каштанова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kashtanova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каштанова Елена Владимировна - д.б.н.</p><p>Новосибирск</p><p>Researcher ID J-4675-2016; Scopus Author ID 8645249000</p></bio><bio xml:lang="en"><p>Elena V. Kashtanova - MD, PhD in biology.</p><p>Novosibirsk</p><p>Researcher ID J-4675-2016; Scopus Author ID 8645249000</p></bio><email xlink:type="simple">elekastanova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9270-9188</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щербакова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shcherbakova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Щербакова Лилия Валерьевна.</p><p>Новосибирск</p><p>Researcher ID ABA-9069-2021; Scopus Author ID 15030341800</p></bio><bio xml:lang="en"><p>Liliya V. Shcherbakova.</p><p>Novosibirsk</p><p>Researcher ID ABA-9069-2021; Scopus Author ID 15030341800</p></bio><email xlink:type="simple">9584792@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3538-0280</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полонская</surname><given-names>Я. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Polonskaya</surname><given-names>Ya. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полонская Яна Владимировна - д.б.н.</p><p>Новосибирск</p><p>Researcher ID H-4397-2016; Scopus Author ID 57216801775</p></bio><bio xml:lang="en"><p>Yana V. Polonskaya - MD, PhD in biology.</p><p>Novosibirsk</p><p>Researcher ID H-4397-2016; Scopus Author ID 57216801775</p></bio><email xlink:type="simple">yana-polonskaya@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0484-6540</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стахнёва</surname><given-names>Е. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Stakhneva</surname><given-names>E. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Стахнёва Екатерина Михайловна - к.б.н.</p><p>Новосибирск</p><p>Researcher ID R-1589-2016; Scopus Author ID 24774022600</p></bio><bio xml:lang="en"><p>Ekaterina M. Stakhneva - PhD in biology.</p><p>Novosibirsk</p><p>Researcher ID R-1589-2016; Scopus Author ID 24774022600</p></bio><email xlink:type="simple">stahneva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4936-8362</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рагино</surname><given-names>Ю. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ragino</surname><given-names>Yu. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рагино Юлия Игоревна - д.м.н., профессор.</p><p>Новосибирск</p><p>ResearcherID E-9498-2015; Scopus Author ID 6602418274</p></bio><bio xml:lang="en"><p>Yulia I. Ragino - MD, PhD, Professor.</p><p>Novosibirsk</p><p>ResearcherID E-9498-2015; Scopus Author ID 6602418274</p></bio><email xlink:type="simple">ragino@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт терапии и профилактической медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Internal and Preventive Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>06</month><year>2024</year></pub-date><volume>21</volume><issue>3</issue><fpage>252</fpage><lpage>262</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шрамко В.С., Каштанова Е.В., Щербакова Л.В., Полонская Я.В., Стахнёва Е.М., Рагино Ю.И., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Шрамко В.С., Каштанова Е.В., Щербакова Л.В., Полонская Я.В., Стахнёва Е.М., Рагино Ю.И.</copyright-holder><copyright-holder xml:lang="en">Shramko V.S., Kashtanova E.V., Shcherbakova L.V., Polonskaya Y.V., Stakhneva E.M., Ragino Y.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/12938">https://www.omet-endojournals.ru/jour/article/view/12938</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. У людей с избыточным количеством жировой ткани наблюдаются повышенные уровни свободных жирных кислот (СЖК) в крови, что в итоге приводит к нарушениям метаболизма липидов и резистентности к инсулину, которые являются основными факторами в развитии сахарного диабета.</p></sec><sec><title>Цель</title><p>Цель. Изучить содержание СЖК в плазме крови, а также их ассоциации с массой тела у мужчин.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведено одноцентровое обсервационное одномоментное исследование. Выборка формировалась случайным репрезентативным методом, сопоставимая по полу и возрасту. В плазме крови определяли уровни СЖК методом высокоэффективной жидкостной хроматографии с масс-спектрометрией.</p></sec><sec><title>Результаты</title><p>Результаты. В исследование включены 250 мужчин. Отобранные участники были разделены на группы согласно их индексу массы тела (ИМТ): группа 1 — 62 человека с ИМТ≤24,9 кг/м2, группа 2 — 101 человек с ИМТ 25,0–29,9 кг/м2, группа 3 — 87 человек с ИМТ≥30,0 кг/м2. Мужчин с ожирением разделили на группу 4 — 62 человека с ИМТ 30,0–34,9 кг/м2, группу 5 — 19 человек с ИМТ 35,0–39,9 кг/м2, группу 6 — 6 человек с ИМТ≥40,0 кг/м2.</p><p>Содержание докозатетраеновой кислоты было выше в группах 2 (р=0,002) и 5 (р=0,003) при сравнении с группой 1. Содержание гамма-линоленовой кислоты было выше в группе 3, чем в группе 1 (р=0,041). Уровни олеиновой, линолевой, дигомо-гамма-линоленовой, мидовой, арахидоновой, эйкозапентаеновой кислот были выше в группе 5, чем в группе 1 (р=0,007, р=0,023, р=0,004, р=0,019, р=0,006, р=0,001 соответственно), а также чем в группе 2 (р=0,006, р=0,017, р=0,007, р=0,007, р=0,008, р=0,001 соответственно). Содержание нервоновой кислоты выше в группах 1 (р=0,029) и 2 (р=0,012), чем в группе 4. Ожирение ассоциировано с повышением уровня гамма-линоленовой (1,030, 1,006–1,056, р=0,015) и эйкозапентаеновой кислотами (1,061, 1,000–1,125, р=0,045) и снижением уровня нервоновой кислоты (0,953, 0,913–0,994, р=0,027).</p></sec><sec><title>Заключение</title><p>Заключение. Уровни СЖК плазмы крови значительно отличаются у мужчин с нормальной массой тела и наличием ожирения. Содержание олеиновой, гамма-линоленовой, мидовой, дигомо-гамма-линоленовой, арахидоновой, докозатетраеновой и эйкозапентаеновой ЖК были значительно выше у мужчин с ожирением 2 степени. Увеличение уровня гамма-линоленовой и эйкозапентаеновой кислот и снижение уровня нервоновой кислоты ассоциированы с ожирением независимо от возраста.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>BACKGROUND</title><p>BACKGROUND: The people with an excessive amount of adipose tissue have elevated levels of free fatty acids (FFA) in the blood, which ultimately leads to disorders of lipid metabolism and insulin resistance, which are the main factors in the development of diabetes mellitus.</p></sec><sec><title>AIM</title><p>AIM: To study the content of FFA in blood plasma, as well as their association with body weight in men.</p></sec><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS: A single-center observational one-stage study was conducted. The sample was formed by a random representative method, comparable by sex and age. The levels of FFA were determined in the blood plasma by high-performance liquid chromatography with mass spectrometry.</p></sec><sec><title>RESULTS</title><p>RESULTS: The study included 250 men. The selected participants were divided into groups according to their body mass index (BMI): Group 1 — 62 people with BMI≤24.9 kg/m2, Group 2 — 101 people with BMI 25.0–29.9 kg/m2, Group 3 — 87 people with BMI≥30.0 kg/m2. Obese men were divided into: Group 4 — 62 people with BMI 30.0–34.9 kg/m2, Group 5 — 19 people with BMI 35.0–39.9 kg/m2, Group 6 — 6 people with BMI≥40.0 kg/m2.</p><p>The content of docosatetraenoic acid was higher in groups 2 (p=0.002) and 5 (p=0.003), when compared with group 1. The content of gamma-linolenic acid was higher in group 3 than in group 1 (p=0.041). Concentration of oleic; linoleic; dihomo-gamma-linolenic; midic; arachidonic; eicosapentaenoic acids were higher in group 5 than in group 1 (p=0.007, p=0.023, p=0.004, p=0.019, p=0.006, p=0.001, respectively), and also than in group 2 (p=0.006, p=0.017, p=0.007, p=0.007, p=0.008, p=0.001, respectively). The content of nervonic acid is higher in groups 1 (p=0.029) and 2 (p=0.012) than in group 4. Obesity is associated with increased levels of gamma-linolenic (1.030, 1.006–1.056, p=0.015) and eicosapentaenoic acids (1.061, 1.000–1.125, p=0.045), and a decrease in the level of nervonic acid (0.953, 0.913–0.994, p=0.027).</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: The FFA levels of blood plasma is significantly different in men with normal body weight and the presence of obesity. The content of oleic, gamma-linolenic, midic, digomo-gamma-linolenic, arachidonic, docosatetraenoic and ­eicosapentaenoic acids was significantly higher in men with grade 2 obesity. An increase in the level of gamma-linolenic and eicosapentaenoic acids, and a decrease in the level of nervonic acid are associated with obesity, regardless of the age.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>индекс массы тела</kwd><kwd>кровь</kwd><kwd>жирные кислоты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>оbesity</kwd><kwd>body mass index</kwd><kwd>blood</kwd><kwd>fatty acids</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа проведена в рамках бюджетной темы по Государственному заданию № FWNR-2024-0004.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315. doi: https://doi.org/10.1016/j.biopha.2021.111315</mixed-citation><mixed-citation xml:lang="en">Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315. doi: https://doi.org/10.1016/j.biopha.2021.111315</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Алфёрова В.И., Мустафина С.В. Распространенность ожирения во взрослой популяции Российской Федерации (обзор литературы) // Ожирение и метаболизм. — 2022. — Т. 19. — №1. — С. 96-105. doi: https://doi.org/10.14341/omet12809</mixed-citation><mixed-citation xml:lang="en">Alferova VI, Mustafina SV. The prevalence of obesity in the adult population of the Russian Federation (literature review). Obesity and metabolism. 2022;19(1):96-105. (In Russ.) doi: https://doi.org/10.14341/omet12809</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Simopoulos AP. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8:128. doi: https://doi.org/10.3390/nu8030128</mixed-citation><mixed-citation xml:lang="en">Simopoulos AP. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8:128. doi: https://doi.org/10.3390/nu8030128</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ichimura A, Hasegawa S, Kasubuchi M, et al. Free fatty acid receptors as therapeutic targets for the treatment of diabetes. Front. Pharmacol. 2014;5:236. doi: https://doi.org/10.3389/fphar.2014.00236</mixed-citation><mixed-citation xml:lang="en">Ichimura A, Hasegawa S, Kasubuchi M, et al. Free fatty acid receptors as therapeutic targets for the treatment of diabetes. Front. Pharmacol. 2014;5:236. doi: https://doi.org/10.3389/fphar.2014.00236</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ebbert JO, Jensen MD. Fat depots, free fatty acids, and dyslipidemia. Nutrients. 2013;5(2):498-508. doi: https://doi.org/10.3390/nu5020498</mixed-citation><mixed-citation xml:lang="en">Ebbert JO, Jensen MD. Fat depots, free fatty acids, and dyslipidemia. Nutrients. 2013;5(2):498-508. doi: https://doi.org/10.3390/nu5020498</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Longo M. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. International journal of molecular sciences. 2019;20(9):2358. doi: https://doi.org/10.3390/ijms20092358</mixed-citation><mixed-citation xml:lang="en">Longo M. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. International journal of molecular sciences. 2019;20(9):2358. doi: https://doi.org/10.3390/ijms20092358</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Вельков В.В. Свободные жирные кислоты новый маркер инсулинорезистентности и ишемии // Дальневосточный медицинский журнал. — 2008. — 4. — С. 120-122.</mixed-citation><mixed-citation xml:lang="en">Velkov VV. Free fatty acids are a new marker of insulin resistance and ischemia. Far Eastern Medical Journal. 2008;4:120-122 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Исаева А.П., Гаппарова К.М., Чехонина Ю.Г., и др. Свободные жирные кислоты и ожирение: состояние проблемы // Вопросы питания. — 2018. — Т. 87. — №1. — С. 18-27. doi: https://doi.org/10.24411/0042-8833-2018-10002</mixed-citation><mixed-citation xml:lang="en">Isaeva AP, Gapparova KM, Chekhonina YuG, et al. Characteristics of free fatty acid metabolism in pathogenesis of obesity: current view. Nutrition issues. 2018; 87(1): 18–27. (In Russ.). doi: https://doi.org/10.24411/0042-8833-2018-10002</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ataey A, Jafarvand E, Adham D, et al. The Relationship Between Obesity, Overweight, and the Human Development Index in World Health Organization Eastern Mediterranean Region Countries. J Prev Med Public Health. 2020; 53(2):98-105. doi: https://doi.org/10.3961/jpmph.19.100</mixed-citation><mixed-citation xml:lang="en">Ataey A, Jafarvand E, Adham D, et al. The Relationship Between Obesity, Overweight, and the Human Development Index in World Health Organization Eastern Mediterranean Region Countries. J Prev Med Public Health. 2020; 53(2):98-105. doi: https://doi.org/10.3961/jpmph.19.100</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Родионова Т.И., Тепаева А.И. Ожирение — глобальная проблема современного общества // Фундаментальные исследования. — 2012. — Т.12 №1. — С. 132-136.</mixed-citation><mixed-citation xml:lang="en">Rodionova TI, Tepaeva AI. Obesity — the global problem of modern society. Fundamental research. 2012;12 (1):132-136. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mozaffarian D, Benjamin EJ, Go AS. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation. 2015;131(4):e29-e39. doi: https://doi.org/10.1161/CIR.0000000000000152</mixed-citation><mixed-citation xml:lang="en">Mozaffarian D, Benjamin EJ, Go AS. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation. 2015;131(4):e29-e39. doi: https://doi.org/10.1161/CIR.0000000000000152</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ma XL, Meng L, Li LL, et al. Plasma Free Fatty Acids Metabolic Profile Among Uyghurs and Kazaks With or Without Type 2 Diabetes Based on GC-MS. Exp Clin Endocrinol Diabetes. 2018;126(10):604-611. doi: https://doi.org/10.1055/s-0043-121263</mixed-citation><mixed-citation xml:lang="en">Ma XL, Meng L, Li LL, et al. Plasma Free Fatty Acids Metabolic Profile Among Uyghurs and Kazaks With or Without Type 2 Diabetes Based on GC-MS. Exp Clin Endocrinol Diabetes. 2018;126(10):604-611. doi: https://doi.org/10.1055/s-0043-121263</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Xin Y, Wang Y, Chi J, et al. Elevated free fatty acid level is associated with insulin-resistant state in nondiabetic Chinese people. Diabetes Metab Syndr Obes. 2019;12:139-147. doi: https://doi.org/10.2147/DMSO.S186505</mixed-citation><mixed-citation xml:lang="en">Xin Y, Wang Y, Chi J, et al. Elevated free fatty acid level is associated with insulin-resistant state in nondiabetic Chinese people. Diabetes Metab Syndr Obes. 2019;12:139-147. doi: https://doi.org/10.2147/DMSO.S186505</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Capurso C, Capurso A. From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol. 2012;57(2-4):91-7. doi: https://doi.org/10.1016/j.vph.2012.05.003</mixed-citation><mixed-citation xml:lang="en">Capurso C, Capurso A. From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol. 2012;57(2-4):91-7. doi: https://doi.org/10.1016/j.vph.2012.05.003</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen G, Shamni O, Avrahami Y, et al. Beta cell response to nutrient overload involves phospholipid remodelling and lipid peroxidation. Diabetologia. 2015;58(6):1333-43. doi: https://doi.org/10.1007/s00125-015-3566-z</mixed-citation><mixed-citation xml:lang="en">Cohen G, Shamni O, Avrahami Y, et al. Beta cell response to nutrient overload involves phospholipid remodelling and lipid peroxidation. Diabetologia. 2015;58(6):1333-43. doi: https://doi.org/10.1007/s00125-015-3566-z</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Schwingshackl L, Hoffmann G. Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients. 2012;11;4(12):1989-2007. doi: https://doi.org/10.3390/nu4121989</mixed-citation><mixed-citation xml:lang="en">Schwingshackl L, Hoffmann G. Monounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients. 2012;11;4(12):1989-2007. doi: https://doi.org/10.3390/nu4121989</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Shramko VS, Polonskaya YV, Kashtanova EV, et al. The Short Overview on the Relevance of Fatty Acids for Human Cardiovascular Disorders. Biomolecules. 2020; 10(8):1127. doi: https://doi.org/10.3390/biom10081127</mixed-citation><mixed-citation xml:lang="en">Shramko VS, Polonskaya YV, Kashtanova EV, et al. The Short Overview on the Relevance of Fatty Acids for Human Cardiovascular Disorders. Biomolecules. 2020; 10(8):1127. doi: https://doi.org/10.3390/biom10081127</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Людинина А.Ю., Бойко Е.Р. Функциональная роль мононенасыщенных жирных кислот в организме человека // Успехи физиологических наук. — 2013. — Т. 44. — №4. — С. 51-64.</mixed-citation><mixed-citation xml:lang="en">Lyudinina AYu, Boyko ER. The functional role of monounsaturated fatty acids in the human body. Successes of physiological sciences. 2013; 44 (4):51-64. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Warensjö E, Sundström J, Vessby B, Cederholm T, Risérus U. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr. 2008;88(1):203-209. doi: https://doi.org/10.1093/ajcn/88.1.203</mixed-citation><mixed-citation xml:lang="en">Warensjö E, Sundström J, Vessby B, Cederholm T, Risérus U. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr. 2008;88(1):203-209. doi: https://doi.org/10.1093/ajcn/88.1.203</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kang M, Lee A, Yoo HJ, Kim M, et al. Association between increased visceral fat area and alterations in plasma fatty acid profile in overweight subjects: a cross-sectional study. Lipids Health Dis. 2017;16(1):248. doi: https://doi.org/10.1186/s12944-017-0642-z</mixed-citation><mixed-citation xml:lang="en">Kang M, Lee A, Yoo HJ, Kim M, et al. Association between increased visceral fat area and alterations in plasma fatty acid profile in overweight subjects: a cross-sectional study. Lipids Health Dis. 2017;16(1):248. doi: https://doi.org/10.1186/s12944-017-0642-z</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gambino R, Bugianesi E, Rosso C, et al. Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load. Int J Mol Sci. 2016;17(4):479. doi: https://doi.org/10.3390/ijms17040479</mixed-citation><mixed-citation xml:lang="en">Gambino R, Bugianesi E, Rosso C, et al. Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load. Int J Mol Sci. 2016;17(4):479. doi: https://doi.org/10.3390/ijms17040479</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sergeant S, Rahbar E, Chilton FH. Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes. Eur J Pharmacol. 2016;785:77-86. doi: https://doi.org/10.1016/j.ejphar.2016.04.020</mixed-citation><mixed-citation xml:lang="en">Sergeant S, Rahbar E, Chilton FH. Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes. Eur J Pharmacol. 2016;785:77-86. doi: https://doi.org/10.1016/j.ejphar.2016.04.020</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hooper L, Al-Khudairy L, Abdelhamid AS, et al. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018;7(7):CD011094. doi: https://doi.org/10.1002/14651858.CD011094.pub3</mixed-citation><mixed-citation xml:lang="en">Hooper L, Al-Khudairy L, Abdelhamid AS, et al. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018;7(7):CD011094. doi: https://doi.org/10.1002/14651858.CD011094.pub3</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Bamford JT, Ray S, Musekiwa A, et al. Oral evening primrose oil and borage oil for eczema. Cochrane Database Syst Rev. 2013;2013(4):CD004416. doi: https://doi.org/10.1002/14651858.CD004416.pub2</mixed-citation><mixed-citation xml:lang="en">Bamford JT, Ray S, Musekiwa A, et al. Oral evening primrose oil and borage oil for eczema. Cochrane Database Syst Rev. 2013;2013(4):CD004416. doi: https://doi.org/10.1002/14651858.CD004416.pub2</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pickens CA, Sordillo LM, Comstock SS, et al. Plasma phospholipids, non-esterified plasma polyunsaturated fatty acids and oxylipids are associated with BMI. Prostaglandins Leukot Essent Fatty Acids. 2015;95:31-40. doi: https://doi.org/10.1016/j.plefa.2014.12.001</mixed-citation><mixed-citation xml:lang="en">Pickens CA, Sordillo LM, Comstock SS, et al. Plasma phospholipids, non-esterified plasma polyunsaturated fatty acids and oxylipids are associated with BMI. Prostaglandins Leukot Essent Fatty Acids. 2015;95:31-40. doi: https://doi.org/10.1016/j.plefa.2014.12.001</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Liu L, Li Y, Guan C, et al. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(28):2817-25. doi: https://doi.org/10.1016/j.jchromb.2010.08.035</mixed-citation><mixed-citation xml:lang="en">Liu L, Li Y, Guan C, et al. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(28):2817-25. doi: https://doi.org/10.1016/j.jchromb.2010.08.035</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Valenzuela R, Ortiz M, Hernández-Rodas MC, et al. Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease. Curr Med Chem. 2020;27(31):5250-5272. doi: https://doi.org/10.2174/0929867326666190410121716</mixed-citation><mixed-citation xml:lang="en">Valenzuela R, Ortiz M, Hernández-Rodas MC, et al. Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease. Curr Med Chem. 2020;27(31):5250-5272. doi: https://doi.org/10.2174/0929867326666190410121716</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Borow KM, Nelson JR, Mason RP. Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis. Atherosclerosis. 2015;242(1):357-66. doi: https://doi.org/10.1016/j.atherosclerosis.2015.07.035</mixed-citation><mixed-citation xml:lang="en">Borow KM, Nelson JR, Mason RP. Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis. Atherosclerosis. 2015;242(1):357-66. doi: https://doi.org/10.1016/j.atherosclerosis.2015.07.035</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dewailly E, Blanchet C, Gingras S, et al. Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr. 2002;76(1):85-92. doi: https://doi.org/10.1093/ajcn/76.1.85</mixed-citation><mixed-citation xml:lang="en">Dewailly E, Blanchet C, Gingras S, et al. Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr. 2002;76(1):85-92. doi: https://doi.org/10.1093/ajcn/76.1.85</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Alsharari ZD, Risérus U, Leander K, et al. Serum Fatty Acids, Desaturase Activities and Abdominal Obesity - A Population-Based Study of 60-Year Old Men and Women. PLoS One. 2017;12(1):e0170684. doi: https://doi.org/10.1371/journal.pone.0170684</mixed-citation><mixed-citation xml:lang="en">Alsharari ZD, Risérus U, Leander K, et al. Serum Fatty Acids, Desaturase Activities and Abdominal Obesity - A Population-Based Study of 60-Year Old Men and Women. PLoS One. 2017;12(1):e0170684. doi: https://doi.org/10.1371/journal.pone.0170684</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Sikorska-Wiśniewska M, Mika A, Śledziński T, et al. Disorders of serum omega-3 fatty acid composition in dialyzed patients, and their associations with fat mass. Ren Fail. 2017;39(1):406-412. doi: https://doi.org/10.1080/0886022X.2017.1295870</mixed-citation><mixed-citation xml:lang="en">Sikorska-Wiśniewska M, Mika A, Śledziński T, et al. Disorders of serum omega-3 fatty acid composition in dialyzed patients, and their associations with fat mass. Ren Fail. 2017;39(1):406-412. doi: https://doi.org/10.1080/0886022X.2017.1295870</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Albracht-Schulte K, Gonzalez S, Jackson A, et al. Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells. Nutrients. 2019;11(3):599. doi: https://doi.org/10.3390/nu11030599</mixed-citation><mixed-citation xml:lang="en">Albracht-Schulte K, Gonzalez S, Jackson A, et al. Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells. Nutrients. 2019;11(3):599. doi: https://doi.org/10.3390/nu11030599</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Fan Y, Meng HM, Hu GR, et al. Biosynthesis of nervonic acid and perspectives for its production by microalgae and other microorganisms. Appl Microbiol Biotechnol. 2018;102(7):3027-3035. doi: https://doi.org/10.1007/s00253-018-8859-y</mixed-citation><mixed-citation xml:lang="en">Fan Y, Meng HM, Hu GR, et al. Biosynthesis of nervonic acid and perspectives for its production by microalgae and other microorganisms. Appl Microbiol Biotechnol. 2018;102(7):3027-3035. doi: https://doi.org/10.1007/s00253-018-8859-y</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Pellegrini CN, Buzkova P, Lichtenstein AH, et al. Individual non-esterified fatty acids and incident atrial fibrillation late in life. Heart. 2021;107(22):1805-1812. doi: https://doi.org/10.1136/heartjnl-2020-317929</mixed-citation><mixed-citation xml:lang="en">Pellegrini CN, Buzkova P, Lichtenstein AH, et al. Individual non-esterified fatty acids and incident atrial fibrillation late in life. Heart. 2021;107(22):1805-1812. doi: https://doi.org/10.1136/heartjnl-2020-317929</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Delgado GE, Krämer BK, Lorkowski S, et al. Individual omega-9 monounsaturated fatty acids and mortality-The Ludwigshafen Risk and Cardiovascular Health Study. J Clin Lipidol. 2017;11(1):126-135.e5. doi: https://doi.org/10.1016/j.jacl.2016.10.015</mixed-citation><mixed-citation xml:lang="en">Delgado GE, Krämer BK, Lorkowski S, et al. Individual omega-9 monounsaturated fatty acids and mortality-The Ludwigshafen Risk and Cardiovascular Health Study. J Clin Lipidol. 2017;11(1):126-135.e5. doi: https://doi.org/10.1016/j.jacl.2016.10.015</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Oda E, Hatada K, Kimura J, et al. Relationships between serum unsaturated fatty acids and coronary risk factors: negative relations between nervonic acid and obesity-related risk factors. Int Heart J. 2005;46(6):975-85. doi: https://doi.org/10.1536/ihj.46.975</mixed-citation><mixed-citation xml:lang="en">Oda E, Hatada K, Kimura J, et al. Relationships between serum unsaturated fatty acids and coronary risk factors: negative relations between nervonic acid and obesity-related risk factors. Int Heart J. 2005;46(6):975-85. doi: https://doi.org/10.1536/ihj.46.975</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Fox TE, Bewley MC, Unrath KA, et al. Circulating sphingolipid biomarkers in models of type 1 diabetes. J Lipid Res. 2011;52(3):509-17. doi: https://doi.org/10.1194/jlr.M010595</mixed-citation><mixed-citation xml:lang="en">Fox TE, Bewley MC, Unrath KA, et al. Circulating sphingolipid biomarkers in models of type 1 diabetes. J Lipid Res. 2011;52(3):509-17. doi: https://doi.org/10.1194/jlr.M010595</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Yamazaki Y, Kondo K, Maeba R, et al. Proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome. J Oleo Sci. 2014;63(5):527-37. doi: https://doi.org/10.5650/jos.ess13226</mixed-citation><mixed-citation xml:lang="en">Yamazaki Y, Kondo K, Maeba R, et al. Proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome. J Oleo Sci. 2014;63(5):527-37. doi: https://doi.org/10.5650/jos.ess13226</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y, Botolin D, Xu J, et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res. 2006;47(9):2028-41. doi: https://doi.org/10.1194/jlr.M600177-JLR20</mixed-citation><mixed-citation xml:lang="en">Wang Y, Botolin D, Xu J, et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res. 2006;47(9):2028-41. doi: https://doi.org/10.1194/jlr.M600177-JLR20</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
